Skip to content

Eli Lilly LLY Current Debt

Current Debt at other companies

Pfizer logo
PfizerPFE
$3.86B+3.0%
Amgen logo
AmgenAMGN
$5.44B+61.4%
McKesson logo
McKessonMCK
$1.13B-53.3%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$0-100%
AbbVie logo
AbbVieABBV
$0-100%

Other financials

Income statement

See full
Revenue$19.8B+55.5%
Gross profit$16.2B+54.4%
Net income$7.4B+168%
EPS (diluted)$8.26+170%

Balance sheet

See full
Cash & equivalents$5.3B+70.8%
Total debt$43.4B+12.6%
Total equity$31.2B+97.9%
Total assets$116.58B+30.4%

Cash flow

See full
Operating cash flow$5.3B+220%
CapEx$2.3B+54.0%
Free cash flow$3.0B+1,828%

Valuation

See full
Market cap$1.09T+58.9%
Enterprise value$1.13T+56.2%
P/E43.1×-6.6×
P/S15.1×+2.2×

Profitability

See full
Gross margin82.8%+1.1pp
Net margin35%+12.3pp
FCF margin16.4%+8.7pp

Returns & leverage

See full
Return on equity107.6%+29.9pp
Debt / equity1.4×-1.1×
Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:DebtCurrent.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's current debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Eli Lilly's current debt?
Eli Lilly (LLY) reported current debt of $4B in Q1 2026.
How has Eli Lilly's current debt changed year-over-year?
Eli Lilly's current debt decreased by 0.4% year-over-year, from $4.02B to $4B.
What is the long-term trend for Eli Lilly's current debt?
Over 5 years (2020 to 2025), Eli Lilly's current debt has grown at a 185.0% compound annual growth rate (CAGR), from $8.7M to $1.64B.
What does current debt mean?
The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.